Stock Analysis

If you are wondering whether Catalyst Pharmaceuticals at around US$24.94 is still sensibly priced or already stretched, you are not […]

If you are wondering whether Fortinet at around US$76.70 still offers value after a weak share price patch, this article

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. With

Investors may be considering whether Marathon Petroleum, at a recent close of US$222.62, still offers value or if most of

Wondering if AT&T at around US$26.46 is a bargain or just fairly priced? This section will help you work out

If you are wondering whether Etsy’s current share price gives you value for your money, it helps to look past

Wondering whether Nutanix at around US$34.41 is a bargain or a value trap? This article breaks down what that price

If you are wondering whether Ares Management at around US$104.80 is a bargain or looks expensive, this article walks through

Replimune Group shares are down on Thursday. The company faces an upcoming FDA review decision on Friday, 10 April. In

Viatris (VTRS) is back on many investors’ screens after its recent share price pullback, with the stock closing at US$13.47